OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-κB pathway.

导出 OA

翻译打印收藏纠错

第一作者： Mohamed Jalloul,Nsaibia

第一单位： Laboratory of Cardiovascular Pathobiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec/Quebec Heart and Lung Institute, Research Center, Department of Surgery, Laval University, 2725 Chemin Ste-Foy, Quebec, Quebec G1V-4G5, Canada.

作者： Mohamed Jalloul,Nsaibia ^[1] ; Marie-Chloé,Boulanger ^[1] ; Rihab,Bouchareb ^[1] ; Ghada,Mkannez ^[1] ; Khai,Le Quang ^[1] ; Fayez,Hadji ^[1] ; Deborah,Argaud ^[1] ; Abdellaziz,Dahou ^[2] ; Yohan,Bossé ^[2] ; Marlys L,Koschinsky ^[3] ; Philippe,Pibarot ^[2] ; Benoit J,Arsenault ^[2] ; André,Marette ^[2] ; Patrick,Mathieu ^[1]

作者单位： Laboratory of Cardiovascular Pathobiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec/Quebec Heart and Lung Institute, Research Center, Department of Surgery, Laval University, 2725 Chemin Ste-Foy, Quebec, Quebec G1V-4G5, Canada. ^[1] Institut Universitaire de Cardiologie et de Pneumologie de Québec/Quebec Heart and Lung Institute, Research Center, Laval University, Quebec, Canada. ^[2] Western University, 1151 Richmond St, London N6A-5B7, Ontario, Canada. ^[3]